Although infrequent, respiratory viral infections (RVIs) during birth hospitalization have a
significant impact on short-and long-term morbidity in term and preterm neonates. RVI have …

Oseltamivir is the main medicine recommended by the World Health Organization in
anticipation of next influenza pandemic. This anti-influenza viral agent is an ester prodrug …

Although influenza vaccination remains the primary method for the prevention of influenza,
efficacy may be limited by a poor match between the vaccine and circulating strains and the …

Influenza virus is a main cause of acute respiratory tract infections (ARTIs) in children. This is
the first double-blind, randomized, and controlled clinical trial examining the efficacy of nasal …

Mao-to is a Japanese traditional herbal medicine which has been used since ancient times
for the treatment of influenza-like illness. This study was conducted to evaluate the effect of …

OBJECTIVES Antivirals are recommended for children hospitalized with influenza but are
underutilized. We describe antiviral prescribing during influenza admissions in Canadian …

The present document outlines current guidelines and supporting literature relating to the
use of antiviral drugs for chemoprophylaxis and influenza illness therapy in paediatric and …

Oseltamivir is a neuraminidase inhibitor widely used to treat and prevent influenza A and B
infections, although its safety and pharmacokinetics have not been evaluated in patients …

Use of antiviral drugs for seasonal influenza: Foundation document for practitioners—Update
2019 | Journal of the Association of Medical Microbiology and Infectious Disease Canada …

Influenza has historically been an uncommon illness in the newborn period, although
epidemic outbreaks in neonatal intensive care units have been described. There is currently …